epilepsy
Neurology · 2019–2019
No submission for this condition has carried consumer input, including the one made since the comments facility came into use.
Every decision
| Medicine | Meeting | Outcome | Consumer input |
|---|---|---|---|
| primidone Management of grand mal and psychomotor (temporal lobe) epilepsy, focal or Jacksonian seizures, myoclonic jerks and akinetic attacks. Temporary listing to… | Nov 2019 | Recommended with restriction | no section in document |
What the PBS pays
$1M in government benefit over 2024–25, across 14,256 services.
This is spend on the medicines considered for this condition, not spend on the disease. A medicine used for several conditions is counted in full under each, so figures across conditions add to more than national PBS expenditure.
| Medicine | Government benefit |
|---|---|
| primidone | $0.9M |
Registered, not subsidised
Medicines on the ARTG for this condition with no PBAC record at all. Registration and subsidy are separate decisions: a medicine can be legally available in Australia and never have been put to the committee.
| Medicine | On the ARTG since | Registrations |
|---|---|---|
| lamotrigineAPX-LAMOTRIGINE lamotrigine 100 mg dispersible/chewable tablet blister | 1993 | 115 |
| sodium valproateAPO-Sodium Valproate 200 mg tablet blister pack | 1991 | 38 |
| carbamazepineAVLOIRE CR 200 carbamazepine 200 mg tablet blister pack | 1991 | 11 |
| phenytoinDBL PHENYTOIN INJECTION 100mg/2mL ampoule | 1991 | 8 |
| clonazepamPAXAM 0.5 clonazepam 0.5mg tablet bottle | 1991 | 5 |
| phenobarbitalORION PHENOBARBITAL ELIXIR phenobarbital 15mg/5mL oral liquid bottle | 1991 | 4 |
| vigabatrinSABRIL vigabatrin 0.5g powder oral sachetl | 1995 | 2 |
| sulthiameOSPOLOT sulthiame 200 mg tablet bottle | 1991 | 2 |
The ARTG export holds current registrations only, so the year is the earliest entry still on the register rather than a first-registration date. The condition here comes from the registered label, which is usually broader than the population a sponsor asks to have subsidised.
Conditions are classified by a language model from the indication text of each submission, so an individual label here can be wrong. Consumer input is read from the document's own consumer comments section: 0 of 1 decisions since 2014 carried some. Silence means no comment reached the committee through that facility, not that nobody was affected. More on how this was built.